Watson Pharmaceuticals


Watson to add respiratory products with $4.5 million R&D facility

Watson Pharmaceuticals (NYSE:WPI) has said it will build a $4.5 million research and development facility focused on developing respiratory products and inhalation technology in New Jersey. The drugmaker does not currently have a respiratory or inhalation platform, “so we will be establishing that organically,” a spokeswoman for the company said. About 50 new and current […]


FDA panel votes no on Watson Pharma, Columbia Labs’ preterm birth gel

A U.S. Food and Drug Administration panel has voted against Columbia Laboratories‘ (Nasdaq: CBRX) and Watson Pharmaceuticals’ (NYSE: WPI) progesterone vaginal gel 8% to reduce preterm birth in women, saying the panel requires more information. The Advisory Committee for Reproductive Health Drugs said the gel did not produce a statistically significant reduction in preterm births […]


Teva, Ferring boost Antares Pharma product sales

Antares Pharma product sales soared 41 percent in the first nine months of 2011 to $5.8 million, helped in part by customers Teva (NASDAQ: TEVA) and Ferring Pharmaceutical. The Ewing, New Jersey company focuses on needle-free self-injection pharmaceutical products and topical gel-based medicines and partners with larger companies such as Teva and Watson Pharmaceuticals (NYSE: […]


Watson gears up for generic Lipitor launch

Watson Pharmaceuticals’ (NYSE:WPI) strategy for launching its generic version of Lipitor was the topic of conversation in its third-quarter results as Pfizer’s (NYSE:PFE) exclusive patent to the cholesterol drug nears its expiration date. During Watson’s conference call to discuss its quarterly earnings, CEO Paul Bisaro said: “Regarding the launch of generic Lipitor later this month, […]

Health IT

Morning Read: Human ‘infects’ himself with computer virus

Highlights of the important and the interesting from the world of healthcare: What happens when a human gets infected by computer virus? A British scientist claims to be the first human “infected” by a computer virus, an experiment he hopes will aid research into the risks associated with implanted electronic medical devices. The scientist deliberately […]


Morning Read: Some good pharma news (finally)

Highlights of the important and the interesting from the world of healthcare: Finally! Some good pharma news: Amid what seems like an endless cascade of merger-inspired Big Pharma layoffs, one bright spot has emerged. Generic drugmaker Watson Pharmaceutics plans to double to 500 its employees in New Jersey over the next few years. It may […]


Mylan receives FDA approval for generic gallstones medication

Generic drugmaker Mylan Pharmaceuticals Inc. has received FDA approval to begin shipping a generic version of a drug that treats gallstones. Ursodial USP is the generic version of Watson Pharmaceuticals’ Actigall capsules. A number of other drugmakers sell Ursodial capsules, including Lannett Company and Teva Pharmaceuticals. Ursodia USP is a bile acid that naturally occurs […]